Vaxcyte
PCVX
#2783
Rank
A$8.81 B
Marketcap
A$67.33
Share price
-3.12%
Change (1 day)
-52.92%
Change (1 year)

Earnings for Vaxcyte (PCVX)

Earnings in 2025 (TTM): -A$1.03 Billion

According to Vaxcyte 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.7 Billion a decrease over its 2023 earnings that were of -A$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vaxcyte from 2019 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.03 Billion46.24%
2024 -A$0.7 Billion15.33%
2023 -A$0.61 Billion80%
2022 -A$0.34 Billion123.31%
2021 -A$0.16 Billion12.17%
2020 -A$0.14 Billion77.46%
2019 -A$75.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.23 Billion-77.48%๐Ÿ‡บ๐Ÿ‡ธ USA